These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 10873543
1. Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization, and preliminary X-ray diffraction analysis. Bourguet W, Andry V, Iltis C, Klaholz B, Potier N, Van Dorsselaer A, Chambon P, Gronemeyer H, Moras D. Protein Expr Purif; 2000 Jul; 19(2):284-8. PubMed ID: 10873543 [Abstract] [Full Text] [Related]
2. Purification and crystallization of the heterodimeric complex of RARbeta and RXRalpha ligand-binding domains in the active conformation. Pogenberg V, Guichou JF, Bourguet W. Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1170-2. PubMed ID: 15159591 [Abstract] [Full Text] [Related]
3. Purification, functional characterization, and crystallization of the ligand binding domain of the retinoid X receptor. Bourguet W, Ruff M, Bonnier D, Granger F, Boeglin M, Chambon P, Moras D, Gronemeyer H. Protein Expr Purif; 1995 Oct; 6(5):604-8. PubMed ID: 8535152 [Abstract] [Full Text] [Related]
4. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H, Moras D. Mol Cell; 2000 Feb; 5(2):289-98. PubMed ID: 10882070 [Abstract] [Full Text] [Related]
5. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D. J Mol Biol; 2001 Mar 23; 307(2):557-76. PubMed ID: 11254382 [Abstract] [Full Text] [Related]
6. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains. Tian K, Norris AW, Lin CL, Li E. Biochemistry; 1997 May 13; 36(19):5669-76. PubMed ID: 9153406 [Abstract] [Full Text] [Related]
7. Versatile copurification procedure for rapid isolation of homogeneous RAR-RXR heterodimers. Iyer J, Bonnier D, Granger F, Iltis C, Andry V, Schultz P, Gronemeyer H. Protein Expr Purif; 1999 Jul 13; 16(2):308-14. PubMed ID: 10419826 [Abstract] [Full Text] [Related]
8. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis. Kammerer S, Germain P, Flaig R, Peluso-Iltis C, Mitschler A, Rochel N, Gronemeyer H, Moras D. Acta Crystallogr D Biol Crystallogr; 2004 Nov 13; 60(Pt 11):2048-50. PubMed ID: 15502323 [Abstract] [Full Text] [Related]
9. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma. Wan H, Hong WK, Lotan R. Cancer Res; 2001 Jan 15; 61(2):556-64. PubMed ID: 11212249 [Abstract] [Full Text] [Related]
10. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. Vivat V, Zechel C, Wurtz JM, Bourguet W, Kagechika H, Umemiya H, Shudo K, Moras D, Gronemeyer H, Chambon P. EMBO J; 1997 Sep 15; 16(18):5697-709. PubMed ID: 9312028 [Abstract] [Full Text] [Related]
11. Analysis of homo- and heterodimerization of retinoid receptors in solution. Venepally P, Reddy LG, Sani BP. Arch Biochem Biophys; 1997 Jul 15; 343(2):234-42. PubMed ID: 9224735 [Abstract] [Full Text] [Related]
12. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. Nature; 1995 Jun 01; 375(6530):377-82. PubMed ID: 7760929 [Abstract] [Full Text] [Related]
13. Coexpression of nuclear receptor partners increases their solubility and biological activities. Li C, Schwabe JW, Banayo E, Evans RM. Proc Natl Acad Sci U S A; 1997 Mar 18; 94(6):2278-83. PubMed ID: 9122185 [Abstract] [Full Text] [Related]
14. Purification of the human RARgamma ligand-binding domain and crystallization of its complex with all-trans retinoic acid. Rochel N, Renaud JP, Ruff M, Vivat V, Granger F, Bonnier D, Lerouge T, Chambon P, Gronemeyer H, Moras D. Biochem Biophys Res Commun; 1997 Jan 13; 230(2):293-6. PubMed ID: 9016769 [Abstract] [Full Text] [Related]
15. The "Phantom Effect" of the Rexinoid LG100754: structural and functional insights. Sato Y, Ramalanjaona N, Huet T, Potier N, Osz J, Antony P, Peluso-Iltis C, Poussin-Courmontagne P, Ennifar E, Mély Y, Dejaegere A, Moras D, Rochel N. PLoS One; 2010 Nov 30; 5(11):e15119. PubMed ID: 21152046 [Abstract] [Full Text] [Related]
16. RAR antagonists diminish the level of DNA binding by the RAR/RXR heterodimer. Poujol N, Margeat E, Baud S, Royer CA. Biochemistry; 2003 May 06; 42(17):4918-25. PubMed ID: 12718533 [Abstract] [Full Text] [Related]
17. Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties. Dong D, Noy N. Biochemistry; 1998 Jul 28; 37(30):10691-700. PubMed ID: 9692959 [Abstract] [Full Text] [Related]
18. Purification and crystallization of the human RXRalpha ligand-binding domain-9-cisRA complex. Egea PF, Moras D. Acta Crystallogr D Biol Crystallogr; 2001 Mar 28; 57(Pt 3):434-7. PubMed ID: 11223524 [Abstract] [Full Text] [Related]
19. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently. Kersten S, Dawson MI, Lewis BA, Noy N. Biochemistry; 1996 Mar 26; 35(12):3816-24. PubMed ID: 8620004 [Abstract] [Full Text] [Related]
20. Auto-silencing by the retinoid X receptor. Kersten S, Dong D, Lee Wy, Reczek PR, Noy N. J Mol Biol; 1998 Nov 20; 284(1):21-32. PubMed ID: 9811539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]